Uploaded August 2026 | Updated September 2026, 3 weeks ago

---

Insilico Medicine is extending its AI drug discovery platform into “virtual cells,” computational models designed to simulate cellular changes across aging, disease, and intervention. By combining biological data with foundation models, the approach aims to model aging biology as a connected system rather than relying on a single biomarker or drug target.

Full Episode on YouTube, Spotify and Apple Podcast. Link in the comment.

#LongevityTechnologyUnlocked #LongevityPodcast #VirtualCells #InsilicoMedicine #AgingBiology #AIDrugDiscovery